Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
11/2003
11/27/2003US20030220388 Indoline derivatives
11/27/2003US20030220375 N-biphenyl(substituted methyl) aminocycloalkane-carboxamide derivatives
11/27/2003US20030220372 Imidazole compounds as anti-inflammatory and analgesic agents
11/27/2003US20030220367 Administering a therapeutical carbamate derivative to a patient as prostaglandin IP (12 or PGI2) antagonists
11/27/2003US20030220358 A1 adenosine receptro antagonists
11/27/2003US20030220349 Related to organ systems which respond to estrogen agonists or antagonists; in particular, 2-phenyl-3-aroylbenzothiophenes and 1-(alkylaminoethoxy phenyl)-1-phenyl-2-phenylbut-1-enes have wide application as estrogen agonists
11/27/2003US20030220341 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/27/2003US20030220339 Heterocyclic arylsulfonamidobenzylic compounds
11/27/2003US20030220332 Useful in the treatment of inter alia benign prostatic hyperplasia
11/27/2003US20030220330 Anilinopyrimidine derivatives as JNK pathway inhibitors and compositions and methods related thereto
11/27/2003US20030220325 Such as 1-(4-(phenylsulfonyl)-naphthyl)piperazine; for treating treating diseases related to 5-HT receptor; radiolabelling
11/27/2003US20030220322 Substituted 3,4-dihydro-pyrimido[1,2a]pyrimidines and 3,4-dihydro-pyrazino[1,2a]pyrimidines, and methods for their preparation and use
11/27/2003US20030220319 Such as 1-(4,5-dihydro-1H-imidazol-2-ylmethyl)-3-methanesulfonyl-2-methyl-1H-indole for preventing/treating disorders modulated by alpha-1A/L adrenoceptors such as urinary incontinence and sexual disorders
11/27/2003US20030220228 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/27/2003US20030219875 Albumin fusion proteins
11/27/2003US20030219439 Genetic enginieered mixtures of complementary determining regions(CDR) antigens used for analyzing neutralizing epitopes and for prophylaxis of allergies and respiratory system disorders
11/27/2003US20030219438 Human antibodies that bind human TNFalpha
11/27/2003US20030219437 Administering antibodies used as antagonists to CD antigen ligands on the cells, for prophylaxis of cardiovascular, gastrointestinal or urogenital disorders
11/27/2003US20030219401 Combination of an aldosterone receptor antagonist and a bile acid sequestering agent
11/27/2003CA2486483A1 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor
11/27/2003CA2486327A1 Htlv-i tax induced killing of p53 null cancer cells
11/27/2003CA2486157A1 Opioid and opioid-like compounds and uses thereof
11/27/2003CA2486147A1 Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies
11/27/2003CA2486106A1 Compounds and methods for inhibiting selectin-mediated function
11/27/2003CA2486092A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
11/27/2003CA2485869A1 Oral therapeutic or preventive drugs for pollakiuria and urinary incontinence or oral sleep inducers, containing tropolone derivatives
11/27/2003CA2485736A1 Methods of treating gastrointestinal and genitourinary pain disorders using venlafaxine and derivatives
11/27/2003CA2485081A1 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
11/27/2003CA2485012A1 1h-imidazo[4,5-c] quinoline derivatives in the treatment of protein kinase dependent diseases
11/27/2003CA2484646A1 Hormone replacement therapy using a combination of conjugated estrogens and trimegestone
11/27/2003CA2484233A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
11/27/2003CA2483619A1 Novel compounds and their use
11/27/2003CA2482756A1 Indole derivatives and the use thereof as cb<sb>2</sb> receptor ligands
11/27/2003CA2482746A1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders
11/27/2003CA2482348A1 Combinations of an ace inhibitor, a calcium channel blocker and a diuretic
11/26/2003EP1365246A1 Diagnostics and therapeutics for diseases associated with neuromedin U2 receptor (NMU2)
11/26/2003EP1364952A1 Bicyclic nitrogenous fused-ring compound
11/26/2003EP1364950A1 Pyridopyrimidine or naphthyridine derivative
11/26/2003EP1364949A1 Jnk inhibitor
11/26/2003EP1364943A1 Novel cystine derivatives and inhibitors for the activation of inflammatory factors
11/26/2003EP1364659A1 Remedies for urinary diseases comprising lpa receptor controlling agents
11/26/2003EP1364023A2 Method of diagnosing and treating cartilage disorders
11/26/2003EP1363944A2 High-affinity antagonists of elr-cxc chemokines
11/26/2003EP1363920A1 Modified psma ligands and uses related thereto
11/26/2003EP1363914A1 Aryl substituted alkylcarboxylic acids as hypocholesterolemic agents
11/26/2003EP1363913A2 Salts of pyrimidine derivatives for use against coronary heart disease and atherosclerose
11/26/2003EP1363909A2 Tricyclic androgen receptor modulator compounds
11/26/2003EP1363904A1 Pyrazoles as tgf inhibitors
11/26/2003EP1363903A1 Indole derivatives and their use as gnrh antagonists
11/26/2003EP1363902A1 Chemical compounds
11/26/2003EP1363899A1 Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists
11/26/2003EP1363898A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1363897A2 Antagonists of mcp-1 function and methods of use thereof
11/26/2003EP1363891A2 Anthrone derivatives and their use as jnk inhibitors
11/26/2003EP1363885A1 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof
11/26/2003EP1363879A2 Sulfide and disulfide compounds and compositions for cholesterol management and related uses
11/26/2003EP1363677A1 Method of using a variant of vegf receptor to treat psoriasis and to enhance wound healing
11/26/2003EP1363640A2 Nucleic acid derivatives
11/26/2003EP1363635A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
11/26/2003EP1363631A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1363629A1 Kappa opioid receptor ligands
11/26/2003EP1363614A2 Use of 2-amino-1(4-hydroxy-2-methanesulphonamidophenyl)ethanol for treating urinary incontinence
11/26/2003EP1363605A1 Gaba-receptor modulators for the treatment of neurodegenerative diseases of the eye
11/26/2003EP1363508A1 Emulsions and aqueous dispersions of phytosterols
11/26/2003EP1268487B1 Tricyclic protein kinase inhibitors
11/26/2003EP1176982B1 Prucalopride oral solution
11/26/2003EP1025096B1 Substituted chroman derivatives
11/26/2003EP1025095B1 Substituted chroman derivatives
11/26/2003EP1000046B1 Piperazine derivatives active on the lower urinary tract
11/26/2003CN1458930A Tartrate salts of thiazolidinedione derivative
11/26/2003CN1458929A Chemokine receptor binding heterocyclic compounds
11/26/2003CN1457873A Process for preparing kidney-tonifying wolfberry fruit capsule
11/26/2003CN1457858A Chinese medicine for treating acute nephritis
11/26/2003CN1457856A Compound toxin-eliminating bolus
11/26/2003CN1457855A Yin-toxin source eliminating pill
11/26/2003CN1457852A Chinese medicine composition for curing traumatic injury and pains in chest and hypochondrium and its preparing method
11/26/2003CN1457840A Medicinal composition for curing urinary system diseases and its preparing method and use
11/26/2003CN1457825A Medicine for curing prostatitis
11/26/2003CN1457785A Doxazosin mesilate slow releasing preparation
11/26/2003CN1128629C Chinese patented medicine for curing urinary stone
11/25/2003USRE38332 Selected soluble esters of hydroxyl-containing indolocarbazoles
11/25/2003US6653508 Use treating various medical conditions, including pain
11/25/2003US6653493 Lipoxin compounds and their use in treating cell proliferative disorders
11/25/2003US6653347 For therapy
11/25/2003US6653313 1,4-dihydropyridine compounds as bradykinin antagonists
11/25/2003US6653310 For therapy of disease states mediated by the chemokine, Interleukin-8 (IL-8)
11/25/2003US6653302 Quinoline and quinazoline compounds useful in therapy
11/25/2003US6653301 For therapy of cancer, diabetes and Alzheimer's disease
11/25/2003US6653300 Pyrazole compounds useful as protein kinase inhibitors
11/25/2003US6652856 Method for the treatment of fibrosis
11/20/2003WO2003095678A1 Ldl receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions
11/20/2003WO2003095613A2 Nucleic acids, polypeptides, and methods for modulating apoptosis
11/20/2003WO2003095451A1 Carbamate-substituted pyrazolopyridines
11/20/2003WO2003095432A1 Benzimidazole derivatives
11/20/2003WO2003095420A1 Hydroxy tetrahydro-naphthalenylurea derivatives
11/20/2003WO2003094921A2 Utilization of inhibitors of egfr-mediated signal transduction for the treatment of benign prostatic hyperplasia (bph)/prostatic hypertrophy
11/20/2003WO2003094861A2 Bis-benzimidazoles and related compounds as potassium channel modulators
11/20/2003WO2003094853A2 Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
11/20/2003WO2003087062A3 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation
11/20/2003WO2003061696A3 Systems and methods for photodynamic therapy
1 ... 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 ... 562